Advertisement

Prevention of Coronary Heart Disease

Part II. Secondary Prevention of Coronary Heart Disease
  • Marcel Kornitzer
Part of the NATO Advanced Science Institutes Series book series (NSSA, volume 58)

Abstract

I would like to focus this paper on the secondary prevention of coronary heart disease (CHD). Secondary prevention includes those activities that alter favorably the natural history of clinical CHD, that is angina pectoris and myocardial infarction. One should also include all therapeutic manoeuvres that decrease the case fatality rate during the acute phase of a myocardial infarction (MI).

Keywords

Acute Myocardial Infarction Secondary Prevention Stable Angina Coronary Care Unit Coronary Drug Project 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adgey, A.A.J., Nelson, P.G., Scott, M.E., Geddes, J.S., Allen, J.D., Zaidi, S.A., Pantridge, J.F., 1969, Management of ventricular fibrillation outside hospital, Lancet, 1: 1169.PubMedCrossRefGoogle Scholar
  2. Ahlmark, G., Saertre, H., 1976, Long-term treatment with betablockers after myocardial infarction, Europ. J. Clin. Pharmacol., 10: 77.CrossRefGoogle Scholar
  3. Andersen, M.P., Bechsgaard, P., Frederiksen, J., 1979, Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction: Preliminary results, Lancet, 11: 865.CrossRefGoogle Scholar
  4. An International Anticoagulant revieuw group, 1970, Collaborative analysis of long-term anticoagulant administration after acute myocardial infarction, Lancet, 1: 203.Google Scholar
  5. Anticoagulants in acute myocardial infarction: Results of a cooperative clinical trial, 1973, JAMA, 225:724.Google Scholar
  6. Anturance Reinfarction Trial Research Group, 1980, Sulfinpyrazone in the prevention of cardiac death after myocardial infarction, N. Engl. J. Med., 302: 250.CrossRefGoogle Scholar
  7. Aspirin Myocardial Infarction Study Research Group, 1980, A randomized controlled trial of aspirin in persons recovered from myocardial infarction, JAMA, 243: 661.CrossRefGoogle Scholar
  8. Assessment of short-term anticoagulant administration after cardiac infarction, 1969, Report of the Working party on anticoagulant therapy in coronary thrombosis, Br. Med. J., 1: 335.CrossRefGoogle Scholar
  9. Baber, N.S., Wainwright, E.D., Howitt, G., 1980, Multicentre postinfarction trial of propranolol in 49 hospitals in the United Kingdom, Italy and Yugoslavia, Br. Heart J., 44: 96.PubMedCrossRefGoogle Scholar
  10. Barber, J.M., Boyle, D., Chaturvedi, N.C., Singh, N., Walsh, M.J., 1976, Practolol in acute myocardial infarction, Acta Med. Scand., suppl. 587: 213.Google Scholar
  11. Breddin, M., 1979, Multicenter two-years prospective study on the prevention of secondary myocardial infarction by ASA in comparison with ohenprocoumon and placebo? Multicenter Controlled Trials, Ed. J.P. Boisset, C.R. Klimt, Inserm, 76:49.Google Scholar
  12. Burley, D.M., Prout, B.J., Sutton, G.C., Taylor, S.H., Turner, J.R.B., Walker, W.C., 1979, Beta adrenergic receptor blockade in the treatment and prevention of myocardial infarction, VII. Asian-Pacific Congress of Cardiol. Abstr. 52: 6.Google Scholar
  13. Carleton, R.A., Sanders, C.A., Burack, W.R., 1960, Heparin administration after acute myocardial infarction, N. Engl. J. Med., 263: 1002.PubMedCrossRefGoogle Scholar
  14. Carlson, L.A., Danielson, M., Ekberg, I., Klintemar, B., Rosenhamer, G., 1977, Reduction of myocardial reinfarction by the combined treatment with clofibrate and nicotinic acid, Atherosclerosis, 28: 81.PubMedCrossRefGoogle Scholar
  15. Chapman, B.L., 1979, Effect of coronary care on myocardial infarct mortality, Br. Heart J., 42: 386.PubMedCrossRefGoogle Scholar
  16. Cobb, L.A., Alvarez, H., Kopass, M.K., 1976, A rapid response system for out-of-hospital cardiac emergencies, Med. Clin. North Am., 60: 283.Google Scholar
  17. Conti, C.R., 1977, Unstable angina pectoris in Yu PN. Goodwin J.F. (eds): Progress in Cardiology 6. Philadelphia Lea & Febiger p. 51.Google Scholar
  18. Conti C.R., 1978, Current status of randomized prospective study on unstable angina, Adv. Cardiol., 22: 130.Google Scholar
  19. Coronary Drug Project Research Group, 1974, Factors influencing long-term prognosis after recovery from myocardial infarction - Three-year findings of the Coronary Drug Project, J. Chron. Dis., 27: 267.CrossRefGoogle Scholar
  20. Coronary Drug Project Research Group, 1970, Initial findings leading to modifications of its research protocol, JAMA, 214: 1303.CrossRefGoogle Scholar
  21. Coronary Drug Project Research Group, 1972, Findings leading to further modifications of its protocol with respect to dextrothyroxine, JAMA, 220: 996.CrossRefGoogle Scholar
  22. Coronary Drug Project Research Group, 1973, Findings leading to discontinuation of the 2.5 mg/day estrogen group, JAMA, 226: 652.CrossRefGoogle Scholar
  23. Coronary Drug Project Research Group, 1975, Clofibrate and niacin in coronary heart disease, JAMA, 231: 360.CrossRefGoogle Scholar
  24. Coronary Drug Project Research Group, 1976, Aspirin in coronary heart disease, J. Chron. Dis., 29: 625.CrossRefGoogle Scholar
  25. Coronary Drug Project Research Group, 1979, Cigarette smoking as a risk factor in men with a prior history of myocardial infarction, J. Chron. Dis., 32: 415.CrossRefGoogle Scholar
  26. Craig, J.H., Byrne, E., Tiltman, R.C.B., 1978, Changing mortality from ischaemic heart disease and acute myocardial infarction, Med. J. Aust., 2: 461.Google Scholar
  27. Detre, K., Murphy, M.L., Hultgren, H., 1977, Effect of coronary bypass surgery on longevity in high and low risk patients, Lancet, 11: 1243.CrossRefGoogle Scholar
  28. Drapkin, A., Merskey, C., 1972, Anticoagulant therapy after acute myocardial infarction: Relation of therapeutic benefit to patient’s age, sex and severity of infarction, JAMA, 222: 541.PubMedCrossRefGoogle Scholar
  29. Eisenberg, M., Bergner, L., Hallstrol, A., 1979, Paramedic programs and out-of-hospital cardiac arrest: II. Impact on community mortality, AJPH, 69: 39.CrossRefGoogle Scholar
  30. Elwood, P.C., Cochrane, A.L., Burr., M.L., Sweetnam, P.M., Williams, G., Welsby, E., Hugues, S.J., Renton, R., 1974, A randomized controlled trial of acetylsalicylic acid in the secondary prevention of mortality from myocardial infarction, Br. Med. J., 1: 436.PubMedCrossRefGoogle Scholar
  31. Elwood, P.C., Sweetnam, P.M., 1979, Aspirin and secondary morta- lity after myocardial infarction, Lancet, 11: 1313.CrossRefGoogle Scholar
  32. European Coronary Surgery Study Group, 1979, Coronary-artery bypass surgery in stable angina pectoris: Survival at two years, Lancet, 1: 889.Google Scholar
  33. Evemy, K.L., Pentecost, B.L., Intravenous and oral practolol in the acute stages of myocardial infarction, Europ. J. of Cardiol., 7:391.Google Scholar
  34. Gazes, P.C., Mobley Jr., E.M., Faris Jr., H.M., Duncan, R.C., Humphries, G.B., 1973, Preinfarctional (unstable) angina A prospective study - Ten year follow-up. Prognostic significance of electrocardiographic changes, Circulation, 48: 331.PubMedGoogle Scholar
  35. Handley, A.J., Emerson, P.K.A., Fleming, P.R., 1972, Heparin in the prevention of deep vein thrombosis after myocardial infarction, Br. Med. J., 2: 436.PubMedCrossRefGoogle Scholar
  36. Harpur, J.E., Kellett, R.J., Conner, W.T., Galbraith, H.-J.,B., Hamilton, M., Murray, J.J., Swallow, J.H., 1971, Controlled trial of early mobilisation and discharge from hospital in uncomplicated myocardial infarction, Lancet, 11: 1331.Google Scholar
  37. Hunt, D., Sloman, G., Christie, D., Penington, C., 1977, Changing patterns and mortality of acute myocardial infarction in a coronary care unit, Brit. Med. J., 1: 795.PubMedCrossRefGoogle Scholar
  38. Jenkins, C.D., Zyzanski, S.J., Rosenman, R.H., 1976, Risk of new myocardial infarction in middle-aged men with manifest coronary heart disease, Circulation, 53: 342.PubMedGoogle Scholar
  39. Jennings, G., Model, D.G., Jones, M.B.S., Turner, P.P., Bester-man, E.M.M., Kidner, P.H., 1976, Oral disopyramide in prophylaxis of arrhythmias following myocardial infarction, Lancet, 1: 51.PubMedCrossRefGoogle Scholar
  40. Kallio, V., Hümülüinen, H., Luurila, O., Hakkila, J., 1979, Multifactorial intervention programme on patients after myocardial infarction, Trans. of the Europ. Society of Cardiol., Vol. 1. No 2. Dublin.Google Scholar
  41. Kloster, F.E., Kremkau, E.L., Ritzmann, L.W., Rahimtoola, S.H., Rösch, J., Kanarek, P.H., 1979, Coronary bypass for stable angina, N. Engl. J. Med., 300: 149.PubMedCrossRefGoogle Scholar
  42. Leren, P. 1966, The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction. A controlled trial, Acta Med. Scand., suppl. 466.Google Scholar
  43. Liberthson, R.R., Nagel, E.L., Hirschman, J.C., Nussenfeld, S.R., 1974, Prehospital ventricular defibrillation - Prognosis and follow-up course, N. Engl. J. Med., 291: 317.PubMedCrossRefGoogle Scholar
  44. Lie, K.I., Wellens, H.J., van Capelle, F.J., Durrer, D., 1974, Lidocaine in the prevention of primary ventricular fibrillation, N. Engl. J. Med., 291: 1324.PubMedCrossRefGoogle Scholar
  45. Lombardo, M., Selvin, A., Motolese, M., Belli, C., Pedroni, P., 1979, Beta-blocking treatment in 440 cases of acute myocardial infarction: A study with oxprenolol. Abstr. Florence Intern. Meeting M.I., 1979, No C145.Google Scholar
  46. Marmorston, J., Moore, F.J., Hopkins, C.E., Kuzma, O.T., Weiner, J., 1962, Clinical studies of long-term estrogen therapy in men with myocardial infarction, Proc. Soc. Exp. Biol. Med., 110: 400.PubMedGoogle Scholar
  47. Maroko, P.R., Hillis, L.D., Muller, J.E., Tavazzi, L., Heyndrickx, G.R., Ray, M., 1977, Favorable effects of hyaluronidase on electrocardiographics evidence or necrosis in patients with acute myocardial infarction, N. Engl. J. Med., 296: 898.PubMedCrossRefGoogle Scholar
  48. Mather, H.G., Pearson, N.G., Read, K.L.Q., Shaw, D.B., Steed, G.R., Thorne, M.G., Jones, S., Guerrier, C.J., Eraut, C.D., McHugh, P.M., Chowdury, N.R., Jafary, M.H., Wallace, T.J., 1971, Acute myocardial infarction: Home and hospital treatment, Brit. Med. J., 3: 334.Google Scholar
  49. Mather, H.G., Morgan, D.C., Pearson, N.G., Read, K.L.Q., Shaw, D.B., Steed, G.R., Thorne, M.G., Lawrence, C.J., Riley, I.S., 1976, Myocardial infarction: A comparison between home and hospital care for patients, Brit. Med. J., 1: 925.Google Scholar
  50. Morrison, L.M., 1960, Diet in coronary atherosclerosis, JAMA, 173: 884.CrossRefGoogle Scholar
  51. Mulcahy, R., Hickey, N., Graham, I., McKenzie, G., 1975, Factors influencing longterm prognosis in male patients surviving a first coronary attack, Brit. Heart J., 37.Google Scholar
  52. Multicentre International Study, 1975, Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol: A multicentre international study, Br. Med. J., 3: 735.CrossRefGoogle Scholar
  53. National Exercice and Heart Disease Project, 1980, Effects of a prescribed supervised exercice program on mortality and cardiovascular morbidity in myocardial infarctions subjects: A randomized clinical trial, CVD Epidem. Newsletter, Council on Epidem. A.H.A. Ed. NO.0 Barhani, No 28:55.Google Scholar
  54. Norris, R.M., Clarke, E.D., Sammel, N.L., Smith, W.M., Williams, B., 1978, Protective effect of propranolol in treatened myocardial infarction, Lancet, 11: 907.CrossRefGoogle Scholar
  55. Norwegian Multicenter Study Group, 1981, Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction, N. Engl. J. Med., 304: 801.CrossRefGoogle Scholar
  56. Pantridge, J.F., 1974, Prehospital coronary care, Br. Heart J., 36: 233.PubMedCrossRefGoogle Scholar
  57. Pantridge, J.F., Geddes, J.S., 1974, Primary ventricular fibrillation, Eur. J. Cardiol., 1 /4: 335.PubMedGoogle Scholar
  58. Persantine-Aspirin Reinfarction Study (PARIS) Research Group, 1980, The Persantine-Aspirin Reinfarction Study, Circulation, 62: 85.Google Scholar
  59. Pitt, A., Lipp, H., Anderson, S.T., 1971, Lignocaine given prophylactically to patients with acute myocardial infarction, Lancet, 1: 612.PubMedCrossRefGoogle Scholar
  60. Physicians of the Newcastle upon tyne region, 1971, Trial of clofibrate in the treatment of ischaemic heart disease. Five-year study by a Group of Physicians…, Brit. Med. J., 4: 767.Google Scholar
  61. Pohjola, S., Siltanen, P., Romo, M., Hwapakoski, J., 1979, Effect of quitting smoking on the longterm survival after myocardial infarction, Proc. 2nd Scient. Meeting Working Group on Epidem. and Prey. Europ. Society of Cardiol., No 033.Google Scholar
  62. Rawles, J.M., Kenmure, A.C.F., 1976, Controlled trial of oxygen in uncomplicated myocardial infarction, Brit. Med. J., 1: 1121.PubMedCrossRefGoogle Scholar
  63. Report of a Research Committee to the Medical Research Council, 1968, Controlled trial of soya-been oil in myocardial infarction, Lancet, 11: 693.Google Scholar
  64. Report by a Research Committee of the Scottish Society of Physicians, 1971, Ischaemic heart disease: A secondary prevention trial using clofibrate, Brit. Med. J., 4: 775.Google Scholar
  65. Report of the Sixty Plus Reinfarction Study Research Group, 1980, A double-blind trial to assess long-term oral anticoagulant therapy in elderly patients after myocardial infarction, Lancet, 11: 889.Google Scholar
  66. Research Committee, 1965, Low-fat diet in myocardial infarction. A controlled trial, Lancet, 11, 501.CrossRefGoogle Scholar
  67. Rose, G.A., Thomson, W.B., Williams, R.T.J., 1965, Corn oil in treatment of ischaemic heart disease, Brit. Med. J., 1: 1531.PubMedCrossRefGoogle Scholar
  68. Rose, G., 1975, The contribution of intensive coronary care, Brit. J. Prey. Soc. Med., 29: 147.Google Scholar
  69. Rose, G., Hamilton, P.J.S., Keen, H., Reid, D.D., MacCartney, P., Jarrett, R.J., 1977, Myocardial ischaemia, risk factors and death from coronary heart disease, Lancet, 1: 105.PubMedCrossRefGoogle Scholar
  70. Rosenman, R.H., Friedman, M., Jenkins, C.D., Straus, R., Wurm, M., Kositchek, R., 1967, Recurring and fatal myocardial infarction in the Western Collaborative Group Study, Am. J. Cardiol., 19: 771.PubMedCrossRefGoogle Scholar
  71. Scanlon, P.J., Nemickas, R., Moran, J.F., 1973, Accelerated angina pectoris. Clinical, hemodynamic, arteriographic and therapeutic experience in 85 patients, Circulation, 47: 19.PubMedGoogle Scholar
  72. Secondary prevention in myocardial infarction survivors, 1980, J. of the Int. Society & Fed. of Cardiol., Heart Beat No3.Google Scholar
  73. Selzer, A., 1978, Use of anticoagulant agents in acute myocardial infarction: Statistics or Clinical judgment ? Am. J. of Cardiol., 41: 1315.CrossRefGoogle Scholar
  74. Sparrow, D., Dawber, T.R., Colton, T., 1978, The influence of cigarette smoking on prognosis after a first myocardial infarction, J. Chron. Dis., 31: 425.PubMedCrossRefGoogle Scholar
  75. Stamler, J., Pick, R., Katz, L.N., Pick, A., Kaplan, B.M., Berkson, D.M., Century, D., 1963, Effectiveness of estrogens for therapy of myocardial infarction in middle-age men, JAMA, 183: 632.PubMedCrossRefGoogle Scholar
  76. Telford, A.M., Wilson, C., 1981, Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome, Lancet, 1: 1225.PubMedCrossRefGoogle Scholar
  77. Valentine, P.A., Frew, J.L., Mashford, M.L., Sloman, J.G., 1974, Lidocaine in the prevention of sudden death in the pre-hospital phase of acute infarction, N. Engl. J. Med., 291: 1327.PubMedCrossRefGoogle Scholar
  78. Veterans Administration Cooperative Urological Research Group (The), 1967, Treatment and survival of patients with cancer of the prostate, Surg. Gyn. & Obst., 1011.Google Scholar
  79. Wasserman, A.J., Gutterman, L.A., Yoe, K.B., 1966, Anticoagulants in acute myocardial infarction: The failure of anticoagulants to alter mortality in randomized series, Am. Heart J., 71: 43.PubMedCrossRefGoogle Scholar
  80. West, R.R., Henderson, A.H., 1979, Randomized multicentre trial of early mobilisation after uncomplicated myocardial infarction, Brit. Heart J., 42: 381.CrossRefGoogle Scholar
  81. Wilhelmsson, C., Wilhelmsen, L., Vedin, J.A., Tibblin, G., Werkö, L., 1974, Reduction of sudden deaths after myocardial infarction by treatment with alprenolol, Lancet, 1: 1157.CrossRefGoogle Scholar
  82. Wilhelmsson, C., Elmfelt, D., Vedin, J.A., Tibblin, G., Wilhelm-sen, L., 1975, Smoking and myocardial infarction, Lancet, 1: 415.PubMedCrossRefGoogle Scholar
  83. Yusuf, S., Ramsdale, D., Peto, R., Furse, L., Bennett, D., Bray, C., Sleight, P., 1980, Early intravenous atenolol treatment in suspected acute myocardial infarction, Lancet, 11: 273.CrossRefGoogle Scholar
  84. Zainal, N., Carmichael, D.J.S., Griffiths, J.W., Besterman, E.M.M., Kidner, P.H., Gillham, A.D., Summers, G.D., 1977, Oral dispyramide for the prevention of arrhythmias in patients with acute myocardial infarction admitted to open wards, Lancet, 11: 887.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1983

Authors and Affiliations

  • Marcel Kornitzer
    • 1
  1. 1.Laboratory of Epidemiology and Social MedicineFree University of Brussels, Campus ErasmeBrusselsBelgium

Personalised recommendations